Atlas Trials

A Multicenter Real-World Cohort Study of Adebrelimab Injection in the Treatment of Extensive-Stage Small Cell Lung Cancer

Clinical trial NCT06530797 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06530797
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Start date
2024-08-01
Primary completion
2026-09-01
Enrollment
2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.